Biotech

All Articles

Metsera teams up with Amneal to secure down GLP-1 supply

.Along with early period 1 data now out in bush, metabolic condition ensemble Metsera is actually sq...

Rivus articles information to support muscle-sparing weight problems medicine cases

.Rivus Pharmaceuticals has actually revealed the information behind its stage 2 being overweight gai...

BMS spends $110M to form T-cell treatment pact, helping Best acquire opportunity to improve prioritized pipeline

.Bristol Myers Squibb is paying for Excellent Medicine $110 million upfront to establish reagents fo...

Generate increases one more $1B-plus Large Pharma partnership

.Novartis has tattooed a package likely worth more than $1 billion along with Flagship-founded Gener...

Metsera GLP-1 data piece reveals 7.5% effective weight loss at 36 days

.Just recently debuted Metsera is actually unfolding some stage 1 record for its own GLP-1 receptor ...

Flagship really hopes biotechs flock to Mirai to enhance genetic medications

.In the middle of the genetic medicines branches nationality, Front runner Pioneering is unveiling a...

BioAge eyes $180M coming from IPO, personal placement for obesity trials

.BioAge Labs is considering about $180 thousand in initial earnings coming from an IPO as well as an...

Merck's LAG-3 combo neglects colon cancer cells stage 3 research study

.An effort through Merck &amp Co. to open the microsatellite stable (MSS) metastatic colorectal canc...

Spanish VC shuts $200M life sciences fund

.Spain-based Asabys Allies has shut a fund of 180 thousand europeans ($ 200 thousand), cash that is ...

BioAge generates $198M coming from IPO as obesity biotech signs up with Nasdaq

.BioAge Labs is bringing in practically $200 thousand via its own Nasdaq IPO this morning, along wit...